Drug intelligence / Profile preview

SLITone Alternaria

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

SLITone Alternaria is a sublingual immunotherapy (SLIT) product containing standardized extracts of the mold *Alternaria alternata*, designed for the treatment of respiratory allergies such as allergic rhinitis and mild asthma in patients sensitized to *Alternaria* allergens. The therapy works by gradually exposing the immune system to controlled doses of *Alternaria* allergen via sublingual administration, aiming to induce immune tolerance and reduce allergic symptoms over time. The major allergenic component targeted is Alt a 1, which plays a key role in triggering type 2 inflammatory responses associated with allergy symptoms. Clinical studies have shown that SLIT with *Alternaria* extract can significantly improve symptoms and reduce medication use compared to placebo, with a favorable safety profile[2][3][5]. Developed as an etiological (disease-modifying) treatment rather than symptomatic relief, it is particularly indicated for patients whose allergies are not adequately managed by conventional pharmacotherapy.

Brand names
SLITone Alternaria
Other names
Alternaria SLIT
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on SLITone Alternaria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLITone Alternaria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call